Effective immediately, the Morisky Widget is being phased out of existence. Under the settlement agreement with Steven Trubow signed December 2020, MMAS Research LLC was required to transfer all MMAS 4 and 8 derivatives to Dr. Morisky by September 2021,including the Morisky Widget, Morisky.org, all language translations, all licenses including Morisky widget sub-licenses, and copyright registrations relating to MMAS4 and 8 widget software that bear the name Morisky, etc.
Steven Trubow has very limited authorization to investigate specific infringement cases prior to December 2020, terminating in 2023. He is not authorized to issue new MMAS 4 and 8 licenses, only retroactive licenses relating to infringement cases. I remain the sole developer/owner/licensor of the Morisky Medication Adherence Scales 4 and 8 and derivatives.
We are transitioning all Morisky Widget users who request it to a new upgraded HIPAA and GDPR compliant digital format - the MMAR digital platform. Philip Morisky, CEO of MMAR, LLC, will notify Morisky Widget clients of this legal development and assist them in the transition process to avoid unnecessary infringement claims. Thank you very much for your understanding and cooperation during this transition period.
Dr. Donald Morisky
President MMAR, LLC
7/11/2022 07:12:14 pm
Dear Dr Donald Morisky,
7/11/2022 09:22:49 pm
We received your request.
Leave a Reply.
What Our Clients Are Saying
"The team are grateful to Professor Donald E Morisky, Department of Community Health Sciences, UCLA School of Public Health, for granting copyright permission to use the MMAS-8 adherence tool for this research." Online Issue March 2020 - BMJ Quality & Safety 2020;29:286-295